The Alzheimer’s disease (AD) community has been shaken by disappointing clinical trials for treatments created to slow or stop disease progression. Nonetheless, there remain reasons for optimism based on an improved understanding of the pathophysiology and course of the disease… Continue Reading →
The 10th international conference on Clinical Trials in Alzheimer’s Disease (CTAD) welcomed some 1250 delegates to Boston, Massachusetts on Wednesday, November 1, 2017 for a meeting to discuss progress and disappointments in drug development for Alzheimer’s disease (AD). Moving Towards… Continue Reading →
As prevention trials for Alzheimer’s disease move into asymptomatic populations, identifying older individuals who manifest the earliest cognitive signs of Alzheimer’s disease is critical. Computerized cognitive testing has the potential to replace current gold standard paper and pencil measures and… Continue Reading →
© 2025 Aging-news